Description

-Bta--D-Glucopyranosiduronic Acid, 2-[[[4-(Aminosulfonyl)Phenyl]Methyl]Amino]-4,5,7-Trimethyl-6-Benzothiazolyl (9Ci) is a complex, high-purity benzothiazole derivative with a glucuronic acid moiety. This compound is of significant interest for its potential role as a key intermediate or reference standard in advanced pharmaceutical research and diagnostic development. It is primarily utilized by research institutions and pharmaceutical companies engaged in the synthesis of novel therapeutic agents or specialized biochemical probes.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates, particularly those targeting specific enzymatic pathways.
• Biochemical Research: Used as a reference standard or probe in studies involving glucuronidation processes, enzyme inhibition, or receptor binding assays.
• Diagnostic Agent Development: Potential application in the development of contrast agents or labeled compounds for medical imaging and diagnostic tests.
• Analytical Standard: Employed in high-performance liquid chromatography (HPLC) and mass spectrometry (MS) for method development, calibration, and quality control in analytical laboratories.
• Life Science Reagent: Utilized in academic and industrial research to study metabolic pathways and bioconjugation chemistry.

Basic Information

Product Name	-Bta--D-Glucopyranosiduronic Acid, 2-[[[4-(Aminosulfonyl)Phenyl]Methyl]Amino]-4,5,7-Trimethyl-6-Benzothiazolyl (9Ci)
CAS No.	135658-98-9
Molecular Formula	C24H27N3O9S2
Molecular Weight	565.62 g/mol
Synonyms	2-[[[4-(Aminosulfonyl)phenyl]methyl]amino]-4,5,7-trimethyl-6-benzothiazolyl β-D-glucopyranosiduronic acid; 2-((4-Sulfamoylbenzyl)amino)-4,5,7-trimethylbenzo[d]thiazol-6-yl β-D-glucopyranosiduronic acid; Benzenesulfonamide, 4-[[(4,5,7-trimethyl-6-(β-D-glucopyranuronosyloxy)-2-benzothiazolyl)amino]methyl]-; 135658-98-9; Benzothiazole glucuronide derivative; Sulfonamide benzothiazole glucuronic acid conjugate
EINECS	Contact for details

Quality Control

Every batch of this high-value intermediate is produced and analyzed under strict quality management systems. We provide comprehensive Certificates of Analysis (COA) detailing purity, identity, and impurity profiles to ensure it meets the exacting standards required for research and development. Our quality protocols are designed to support compliance with cGMP guidelines where applicable for non-clinical and pre-clinical material supply.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); therefore, the container should be kept tightly sealed in a dry environment. For long-term storage, consider conditions under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residual Solvents (GC)	Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.